Biocon Ltd. — Investor Relations & Filings
Biocon Ltd. is a global biopharmaceutical company focused on developing innovative therapies for chronic conditions such as diabetes, oncology, and autoimmune diseases. The company specializes in the research, development, and manufacture of high-quality biosimilars, generic active pharmaceutical ingredients (APIs), and novel biologics. Its portfolio includes recombinant human insulin, insulin analogs, and monoclonal antibodies. Biocon leverages an integrated business model encompassing advanced research and development, large-scale manufacturing, and global commercialization. By prioritizing affordable innovation, the company aims to enhance access to life-saving treatments across international markets, including the United States, Europe, and emerging economies. Its technical expertise in microbial fermentation and complex protein engineering supports a robust pipeline of complex therapeutics designed to address unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Shareholders meeting | 2026-05-08 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-08 | English | |
| Investor Presentation | 2026-05-08 | English | |
| Monitoring Agency Report | 2026-05-07 | English | |
| Record Date | 2026-05-07 | English | |
| Press Release | 2026-05-07 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 44424232 | Shareholders meeting | 2026-05-08 | English | ||
| 44315704 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-08 | English | ||
| 43955963 | Investor Presentation | 2026-05-08 | English | ||
| 43390572 | Monitoring Agency Report | 2026-05-07 | English | ||
| 43348518 | Record Date | 2026-05-07 | English | ||
| 43348530 | Press Release | 2026-05-07 | English | ||
| 43348544 | Outcome of Board Meeting | 2026-05-07 | English | ||
| 43348559 | Outcome of Board Meeting | 2026-05-07 | English | ||
| 43348574 | Outcome of Board Meeting | 2026-05-07 | English | ||
| 43348589 | Change in Auditors | 2026-05-07 | English | ||
| 43348605 | Dividend | 2026-05-07 | English | ||
| 43348619 | Outcome of Board Meeting | 2026-05-07 | English | ||
| 42162648 | News Verification | 2026-05-06 | English | ||
| 42162683 | Rumour Verification - Regulation 30(11) | 2026-05-06 | English | ||
| 42271037 | Board Meeting — Board Meeting Intimation | 2026-05-04 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Biofil Chemicals & Pharmaceuticals
Produces pharmaceutical formulations, bulk drugs, and plast…
|
BIOFILCHEM | IN | Manufacturing |
|
Biofrontera AG
Biopharmaceutical firm specializing in photodynamic therapy…
|
B8F | DE | Manufacturing |
|
Biofrontera Inc.
A biopharmaceutical company commercializing products for de…
|
BFRI | US | Manufacturing |
|
BioGaia
A healthcare and biotechnology company developing clinicall…
|
BIOG | SE | Manufacturing |
|
BIOGEN INC.
Biotechnology company developing therapies for neurological…
|
BIIB | US | Manufacturing |
|
Bio Green Med Solution, Inc.
A diversified company in the biopharmaceutical and fire saf…
|
BGMS | US | Manufacturing |
|
BIOHARVEST SCIENCES INC.
A biotech firm using a platform to grow plant cells for hea…
|
BHST | CA | Manufacturing |
|
Biohaven Ltd.
Develops therapies for neuroscience, immunology, and oncolo…
|
BHVN | VG | Manufacturing |
|
BioInvent International
Develops novel, first-in-class immuno-modulatory antibodies…
|
BINV | SE | Manufacturing |
|
BIOLIFE SOLUTIONS INC
Manufactures biopreservation media and tools for cell and g…
|
BLFS | US | Manufacturing |
Biocon Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61176/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61176 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61176 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61176 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61176}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Biocon Ltd. (id: 61176)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.